Navigation Links
Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis
Date:7/10/2014

li>GSK's GSK-1278863A: Nearly one-third of nephrologists report high interest in this oral renal anemia product.
  • Shield Therapeutics' ST-10: Nearly a third of nephrologists report high interest in this oral ferric iron therapy.
  • Amgen's Velcalcetide: Should this intravenous therapy for secondary hyperparathyroidism (SHPT) receive FDA approval, nephrologists expect significantly higher usage in the dialysis versus the CKD non-dialysis (ND) setting.
  • OPKO Health's Rayaldee: While familiarity is low, over 40 percent of nephrologists report high interest in this oral Vitamin D therapy used to treat SHPT being tested in CKD stage 3 and stage 4 patients, after review of a product profile.
  • Comments from Decision Resources Group Director Rob Dubman:

    • "Physicians are recalling lower number of pills as one of Velphoro's primary messages from sales representatives. Not surprisingly, we have found that in this and other studies that delivery attributes are not as important compared with efficacy and safety attributes." 

    Additional Resources:

    A special report that is expected to publish later this month entitled The Impact of New Iron-Based Phosphate Binders on the Hyperphosphatemia Market will also help manufacturers understand why and how Velphoro and Keryx Pharmaceutical's Zerenex will be used, if Zerenex receives FDA approval later this year.

    About Decision Resources Group
    Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. Clients rely on this analysis and data to make informed decisions. Find out more at www.DecisionResourcesGroup.com.

    All company, brand, or product names contained in this document may be trademarks or registered trademarks of their
    '/>"/>

    SOURCE Decision Resources Group
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. According to Surveyed Oncologists in the EU5, Zytiga Has Heavily Penetrated Second-Line Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC) and is Displacing Jevtana to Later-Line mCRPC
    2. Surveyed U.S. and European Neurologists Agree that a Therapys Effect on Physical Disability is the Most Important Attribute Influencing Prescribing Decisions in Secondary-Progressive Multiple Sclerosis
    3. Despite the Recent Availability of Xtandi, Zytiga Continues to Dominate the Second-Line Metastatic Castrate-Resistant Prostate Cancer Setting, According to Surveyed U.S. Oncologists and Urologists
    4. Surveyed U.S. Physicians Indicate That Xarelto and Apixaban Will Benefit From the Lack of Use of a Fast-Acting Injectable Anticoagulant in the Treatment and Secondary Prophylaxis of Deep Vein Thrombosis/Pulmonary Embolism
    5. Surveyed U.S. Neurologists Would Prescribe Biogen Idecs Tecfidera to 20 Percent of Their Patients with Relapsing-Remitting Multiple Sclerosis (RR-MS)
    6. Surveyed U.S. Pulmonologists Expect to Treat Nearly 50 Percent of Their Severe, Refractory Asthma Patients With a Biologic or Biosimilar Version of Xolair By the End of 2018
    7. For Treating Clostridium difficile Infections, Surveyed Infectious Disease Specialists Agree That Effect on Recurrence Rate is One of the Drug Attributes that Most Influences Their Prescribing Decisions
    8. The Majority of Surveyed Gastroenterologists in the EU5 Identify Remicade as Their Most Preferred Biologic for the Treatment of Ulcerative Colitis
    9. For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs
    10. For Second- and Subsequent-Line Metastatic Castrate-Resistant Prostate Cancer, Surveyed Oncologists Indicate that Improved Symptom Control and Quality of Life is one of the Greatest Unmet Needs
    11. Rising Drug Resistance is Driving Early-Line Use of Powerful Antibiotics Such as Carbapenems for Gram-Negative Infections, According to Surveyed EU5 Physicians
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/18/2014)... , Oct. 18, 2014  In a ... Campaign (HRC), the nation,s largest lesbian, gay, bisexual ... the use of Truvada for Pre-Exposure Prophylaxis (PrEP). ... used to prevent the spread of a disease ... only brand name anti-HIV drug combination currently approved ...
    (Date:10/17/2014)... , Oct. 17, 2014 UBM Medica US ... a leading online community and information resource for neurologists and ... and Alzheimer disease , with discussions of the ... 1 million Americans have Parkinson disease , more than ... or Lou Gehrig disease. Diagnosis can be difficult ...
    (Date:10/17/2014)... 2014 A victim of medical negligence at the ... with a history of alcohol abuse, a physician and consumer ... 46 today, highlighting how Prop 46 will identify and deter ... The ad pictures a doctor drinking at a ...  Proposition 46 will enact the first law in the nation ...
    Breaking Medicine Technology:HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 2HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 3Neurology Times Features Coverage of Parkinson and Alzheimer Disease 2Neurology Times Features Coverage of Parkinson and Alzheimer Disease 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 2Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 4
    ... Measuring the body temperatures of newborns with ... rectal thermometers, according to a cross-sectional study recently ... thermometry methods are necessary when measuring neonate temperatures. ... at the Sanglah Hospital within the Neonatology Division ...
    ... 15, 2011 Dynatronics Corporation (Nasdaq: DYNT ) ... $1 million open market share repurchase program of the company,s ... of management and our board of directors in the future ... said Kelvyn H. Cullimore, president of Dynatronics. "Based on recent ...
    Cached Medicine Technology:New Study Finds Temporal Artery Thermometry Equivalent to Rectal Thermometry 2Dynatronics Announces $1 Million Stock Buyback Program 2
    (Date:10/20/2014)... October 20, 2014 Zereana Jess-Huff, a 34-year-old ... Maryland 2014 on a platform to think outside the bra. ... uses her position to raise awareness about women’s other lady ... breast cancer. You say the color pink and everybody knows ... for a fact that it has not been won when ...
    (Date:10/20/2014)... (PRWEB) October 20, 2014 ... Voicheck as Assistant Director of their CentralSource ... in managing the innovative turnkey drug sourcing, distribution, ... Matthew brings over 12 years of industry experience, ... Myoderm at the peak of their international success ...
    (Date:10/20/2014)... Final Cut Pro X Plugin developers from ... theme for FCPX filmmakers . , “Fun, cool, and ... Citrus theme” Says Christina Austin, CEO of Pixel Film Studios. ... , Citrus comes with all the tools needed for a ... transitions for added style, a title screen for an introduction, ...
    (Date:10/20/2014)... October 20, 2014 Do you ever ... Here comes a wonderful app Metassessor for teachers, specialists ... company helped its client “Intervention Development LLC” to ... app is designed for iOS 4.3 or later and ... app is optimized for iPhone 5. It is now ...
    (Date:10/19/2014)... Dallas, Texas (PRWEB) October 20, 2014 ... therapeutic development for Partial Seizure, complete with comparative ... target, mechanism of action (MoA), route of administration ... and featured news and press releases. It also ... for Partial Seizure and special features on late-stage ...
    Breaking Medicine News(10 mins):Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4
    ... Ramadoss has added a new twist to the cola row ... added pesticides.// , ,"All carbonated drinks like Pepsi and ... a comprehensive policy on such drinks are needed," he said ... of Madras Medical College. ,Ramadoss added that the issue ...
    ... and Prevention say that mothers who are at a low-risk ... deliver their baby by C-section// rather than vaginally. The report ... Perinatal Care. For the study researchers looked at 5.7 million ... ,In general, neonatal ( ,The overall rate ...
    ... Boston have discovered a new common, noncoding variant in ... with age-related macular degeneration// (AMD), the leading cause ... 60 and older. Their analyses, for the first time, ... to estimate individual risk of advanced AMD. They observed ...
    ... people and the possible link between these changes and the ... Forest University School of Medicine// . ,Comparison of ... disorder with the tissue from normal people will be done ... from the National Institute of Mental Health. ,The ...
    ... Institutet in Sweden and Makerere University in Uganda finds that ... and this is the reason for pregnant women and children ... worst of the four malaria parasites that infect man. It ... of pregnant women, with fatal consequences for both her and ...
    ... claim to have discovered how a specific chemotherapy drug helps ... was conducted on the use of a virus in animals ... led by scientists from the Ohio State University Comprehensive Cancer ... Research Institute, and has been published in the August 22nd ...
    Cached Medicine News:Health News:Cesarean Section May Increase Infant Mortality Rates in Low-Risk Women 2Health News:AMD influenced by Variation in 3 Genes 2Health News:AMD influenced by Variation in 3 Genes 3Health News:Brain changes in schizophrenia to be analyzed 2Health News:Brain changes in schizophrenia to be analyzed 3Health News:Malarial Parasite Hides In Placenta 2Health News:Cancer Drug Helps An Anti-Cancer Virus To Act More Exhaustively 2Health News:Cancer Drug Helps An Anti-Cancer Virus To Act More Exhaustively 3
    Designated most popular model or size. Double-ended. 2 mm wide....
    Heavy. 7.5 mm curved tip....
    Desmarres Infant Retractor...
    2.0 mm cup , straight shaft, Flat handle, length 125.0 mm....
    Medicine Products: